BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Klymkowsky MW, Savagner P. Epithelial-mesenchymal transition: a cancer researcher’s conceptual friend and foe. Am J Pathol. 2009;174:1588-1593. [PMID: 19342369 DOI: 10.2353/ajpath.2009.080545] [Cited by in Crossref: 338] [Cited by in F6Publishing: 325] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Valdivia G, Alonso-Diez Á, Pérez-Alenza D, Peña L. From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review. Front Vet Sci 2021;8:623800. [PMID: 33681329 DOI: 10.3389/fvets.2021.623800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lugli A, Zlobec I, Berger MD, Kirsch R, Nagtegaal ID. Tumour budding in solid cancers. Nat Rev Clin Oncol 2021;18:101-15. [PMID: 32901132 DOI: 10.1038/s41571-020-0422-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
3 Qin G, Dang M, Gao H, Wang H, Luo F, Chen R. Deciphering the protein–protein interaction network regulating hepatocellular carcinoma metastasis. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2017;1865:1114-22. [DOI: 10.1016/j.bbapap.2017.06.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
4 Howe EN, Cochrane DR, Cittelly DM, Richer JK. miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer. PLoS One 2012;7:e49987. [PMID: 23185507 DOI: 10.1371/journal.pone.0049987] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
5 Wegwitz F, Kluth MA, Mänz C, Otto B, Gruner K, Heinlein C, Kühl M, Warnecke G, Schumacher U, Deppert W, Tolstonog GV. Tumorigenic WAP-T mouse mammary carcinoma cells: a model for a self-reproducing homeostatic cancer cell system. PLoS One 2010;5:e12103. [PMID: 20730114 DOI: 10.1371/journal.pone.0012103] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
6 van Denderen BJ, Thompson EW. Cancer: The to and fro of tumour spread. Nature. 2013;493:487-488. [PMID: 23344357 DOI: 10.1038/493487a] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
7 Masszi A, Speight P, Charbonney E, Lodyga M, Nakano H, Szászi K, Kapus A. Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3. J Cell Biol. 2010;188:383-399. [PMID: 20123992 DOI: 10.1083/jcb.200906155] [Cited by in Crossref: 98] [Cited by in F6Publishing: 98] [Article Influence: 8.2] [Reference Citation Analysis]
8 Bruchard M, Ghiringhelli F. [Tumor microenvironment: regulatory cells and immunosuppressive cytokines]. Med Sci (Paris) 2014;30:429-35. [PMID: 24801039 DOI: 10.1051/medsci/20143004018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
9 Agnoletto C, Corrà F, Minotti L, Baldassari F, Crudele F, Cook WJJ, Di Leva G, d'Adamo AP, Gasparini P, Volinia S. Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset. Cancers (Basel) 2019;11:E483. [PMID: 30959764 DOI: 10.3390/cancers11040483] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 18.0] [Reference Citation Analysis]
10 Cheng X, Li Y, Tan J, Sun B, Xiao Y, Fang X, Zhang X, Li Q, Dong J, Li M, Qian H, Yin Z, Yang Z. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial–mesenchymal transition. Cancer Letters 2014;348:77-87. [DOI: 10.1016/j.canlet.2014.03.008] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 8.3] [Reference Citation Analysis]
11 Wang T, Liu Y, Zou JF, Cheng ZS. Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation. PLoS One 2017;12:e0183972. [PMID: 28873461 DOI: 10.1371/journal.pone.0183972] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
12 Frisch SM, Schaller M, Cieply B. Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis. J Cell Sci. 2013;126:21-29. [PMID: 23516327 DOI: 10.1242/jcs.120907] [Cited by in Crossref: 170] [Cited by in F6Publishing: 160] [Article Influence: 18.9] [Reference Citation Analysis]
13 Weidenfeld K, Barkan D. EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes? Front Oncol 2018;8:381. [PMID: 30258818 DOI: 10.3389/fonc.2018.00381] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 13.8] [Reference Citation Analysis]
14 Zhang B, Wang W, Li C, Liu R. Inositol polyphosphate-4-phosphatase type II plays critical roles in the modulation of cadherin-mediated adhesion dynamics of pancreatic ductal adenocarcinomas. Cell Adh Migr 2018;12:548-63. [PMID: 29952716 DOI: 10.1080/19336918.2018.1491496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zhi X, Tao J, Xie K, Zhu Y, Li Z, Tang J, Wang W, Xu H, Zhang J, Xu Z. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer. Cancer Lett 2014;346:104-13. [PMID: 24374017 DOI: 10.1016/j.canlet.2013.12.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
16 Xu ZY, Ding SM, Zhou L, Xie HY, Chen KJ, Zhang W, Xing CY, Guo HJ, Zheng SS. FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition. Int J Biol Sci 2012;8:1130-41. [PMID: 22991501 DOI: 10.7150/ijbs.4769] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
17 Hu H, Wang YL, Wang GW, Wong YC, Wang XF, Wang Y, Xu KX. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer. Urol Oncol 2013;31:1242-53. [PMID: 22226665 DOI: 10.1016/j.urolonc.2011.12.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
18 Ciernikova S, Earl J, García Bermejo ML, Stevurkova V, Carrato A, Smolkova B. Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance? Int J Mol Sci 2020;21:E4091. [PMID: 32521716 DOI: 10.3390/ijms21114091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Li D, Sun H, Sun WJ, Bao HB, Si SH, Fan JL, Lin P, Cui RJ, Pan YJ, Wen SM, Zheng XL, Yu XG. Role of RbBP5 and H3K4me3 in the vicinity of Snail transcription start site during epithelial-mesenchymal transition in prostate cancer cell. Oncotarget 2016;7:65553-67. [PMID: 27566588 DOI: 10.18632/oncotarget.11549] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
20 Mayer P, Reitzenstein U, Warnken M, Enzmann H, Racké K. Insulin action on H292 bronchial carcinoma cells as compared to normal bronchial epithelial cells. Pulm Pharmacol Ther. 2012;25:104-114. [PMID: 22210006 DOI: 10.1016/j.pupt.2011.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
21 West NR, Murray JI, Watson PH. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer. Oncogene. 2014;33:1485-1494. [PMID: 23584474 DOI: 10.1038/onc.2013.105] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 6.7] [Reference Citation Analysis]
22 Matsuoka J, Yashiro M, Doi Y, Fuyuhiro Y, Kato Y, Shinto O, Noda S, Kashiwagi S, Aomatsu N, Hirakawa T. Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFβ signaling. PLoS One. 2013;8:e62310. [PMID: 23690936 DOI: 10.1371/journal.pone.0062310] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 6.2] [Reference Citation Analysis]
23 Jariyal H, Gupta C, Srivastava A. Hyaluronic acid induction on breast cancer stem cells unfolds subtype specific variations in stemness and epithelial-to-mesenchymal transition. Int J Biol Macromol 2020;160:1078-89. [PMID: 32479949 DOI: 10.1016/j.ijbiomac.2020.05.236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R. TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J Cell Sci. 2012;125:1259-1273. [PMID: 22399812 DOI: 10.1242/jcs.095299] [Cited by in Crossref: 188] [Cited by in F6Publishing: 185] [Article Influence: 18.8] [Reference Citation Analysis]
25 Oudard S, Geoffrois L, Guillot A, Chevreau C, Deville J, Falkowski S, Boyle H, Baciuchka M, Gimel P, Laguerre B, Laramas M, Pfister C, Topart D, Rolland F, Legouffe E, Denechere G, Amela EY, Abadie-lacourtoisie S, Gross-goupil M. Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma—Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study. European Journal of Cancer 2016;62:28-35. [DOI: 10.1016/j.ejca.2016.04.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
26 Pellecchia A, Pescucci C, De Lorenzo E, Luceri C, Passaro N, Sica M, Notaro R, De Angioletti M. Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition. Oncogenesis 2012;1:e20. [PMID: 23552736 DOI: 10.1038/oncsis.2012.20] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
27 Yan H, Wu W, Ge H, Li P, Wang Z. Up-Regulation of miR-204 Enhances Anoikis Sensitivity in Epithelial Ovarian Cancer Cell Line Via Brain-Derived Neurotrophic Factor Pathway In Vitro. Int J Gynecol Cancer 2015;25:944-52. [PMID: 25962115 DOI: 10.1097/IGC.0000000000000456] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
28 Guan F, Schaffer L, Handa K, Hakomori SI. Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-{beta}. FASEB J 2010;24:4889-903. [PMID: 20720159 DOI: 10.1096/fj.10-162107] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
29 Chang Q, Hedley D. Emerging applications of flow cytometry in solid tumor biology. Methods 2012;57:359-67. [DOI: 10.1016/j.ymeth.2012.03.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
30 Hong SM, Li A, Olino K, Wolfgang CL, Herman JM, Schulick RD, Iacobuzio-Donahue C, Hruban RH, Goggins M. Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas. Mod Pathol. 2011;24:1237-1247. [PMID: 21552209 DOI: 10.1038/modpathol.2011.74] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
31 Ammer LM, Vollmann-Zwerenz A, Ruf V, Wetzel CH, Riemenschneider MJ, Albert NL, Beckhove P, Hau P. The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma. Cancers (Basel) 2020;12:E2973. [PMID: 33066460 DOI: 10.3390/cancers12102973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Hammers HJ, Verheul HM, Salumbides B, Sharma R, Rudek M, Jaspers J, Shah P, Ellis L, Shen L, Paesante S, Dykema K, Furge K, Teh BT, Netto G, Pili R. Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study. Mol Cancer Ther 2010;9:1525-35. [PMID: 20501804 DOI: 10.1158/1535-7163.MCT-09-1106] [Cited by in Crossref: 128] [Cited by in F6Publishing: 74] [Article Influence: 10.7] [Reference Citation Analysis]
33 Wu Y, Liu H, Shi X, Yao Y, Yang W, Song Y. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget 2015;6:9160-72. [PMID: 25863539 DOI: 10.18632/oncotarget.3247] [Cited by in Crossref: 90] [Cited by in F6Publishing: 111] [Article Influence: 15.0] [Reference Citation Analysis]
34 Savagner P. Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity. Curr Top Dev Biol 2015;112:273-300. [PMID: 25733143 DOI: 10.1016/bs.ctdb.2014.11.021] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 12.7] [Reference Citation Analysis]
35 Hemmings C. Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis. Pathology 2013;45:371-81. [PMID: 23594691 DOI: 10.1097/PAT.0b013e328360b600] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
36 Liu N, Li Y, Su S, Wang N, Wang H, Li J. Inhibition of cell migration by ouabain in the A549 human lung cancer cell line. Oncol Lett 2013;6:475-9. [PMID: 24137350 DOI: 10.3892/ol.2013.1406] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
37 Chouat E, Zehani A, Chelly I, Njima M, Maghrebi H, Bani MA, Njim L, Zakhama A, Haouet S, Kchir N. Tumor budding is a prognostic factor linked to epithelial mesenchymal transition in pancreatic ductal adenocarcinoma. Study report and literature review. Pancreatology. 2018;18:79-84. [PMID: 29233500 DOI: 10.1016/j.pan.2017.11.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
38 Sankpal NV, Fleming TP, Sharma PK, Wiedner HJ, Gillanders WE. A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial-mesenchymal transition in cancer. Oncogene 2017;36:3706-17. [PMID: 28192403 DOI: 10.1038/onc.2016.504] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
39 Shi SJ, Wang LJ, Yu B, Li YH, Jin Y, Bai XZ. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget 2015;6:11652-63. [PMID: 25871474 DOI: 10.18632/oncotarget.3457] [Cited by in Crossref: 182] [Cited by in F6Publishing: 206] [Article Influence: 30.3] [Reference Citation Analysis]
40 Zaldumbide L, Erramuzpe A, Guarch R, Pulido R, Cortés JM, López JI. Snail heterogeneity in clear cell renal cell carcinoma. BMC Cancer 2016;16:194. [PMID: 26951092 DOI: 10.1186/s12885-016-2237-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
41 Han Y, Bi Y, Bi H, Diao C, Zhang G, Cheng K, Yang Z. miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1. Hum Cell. 2016;29:30-36. [PMID: 26337822 DOI: 10.1007/s13577-015-0124-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
42 Shakib H, Rajabi S, Dehghan MH, Mashayekhi FJ, Safari-Alighiarloo N, Hedayati M. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review. Endocrine 2019;66:435-55. [PMID: 31378850 DOI: 10.1007/s12020-019-02030-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
43 Kwon Y, Cukierman E, Godwin AK. Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion. PLoS One 2011;6:e18872. [PMID: 21526198 DOI: 10.1371/journal.pone.0018872] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
44 Nauseef JT, Henry MD. Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle? Nat Rev Urol. 2011;8:428-439. [PMID: 21691304 DOI: 10.1038/nrurol.2011.85] [Cited by in Crossref: 129] [Cited by in F6Publishing: 128] [Article Influence: 11.7] [Reference Citation Analysis]
45 Lefevre M, Rousseau A, Rayon T, Dalstein V, Clavel C, Beby-Defaux A, Pretet JL, Soussan P, Polette M, Lacau Saint Guily J, Birembaut P; Papillophar Study Group. Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study. Br J Cancer 2017;116:362-9. [PMID: 28072763 DOI: 10.1038/bjc.2016.434] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
46 Witz IP. The tumor microenvironment: the making of a paradigm. Cancer Microenviron. 2009;2 Suppl 1:9-17. [PMID: 19701697 DOI: 10.1007/s12307-009-0025-8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 6.8] [Reference Citation Analysis]
47 Kobayashi M, Huang C, Sonobe M, Kikuchi R, Ishikawa M, Imamura N, Kitamura J, Iwakiri S, Itoi K, Yasumizu R, Date H. Snail Expression Is Associated With a Poor Prognosis in Malignant Pleural Mesotheliomas. The Annals of Thoracic Surgery 2013;95:1181-8. [DOI: 10.1016/j.athoracsur.2013.01.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
48 Klotz B, Kneitz S, Regensburger M, Hahn L, Dannemann M, Kelso J, Nickel B, Lu Y, Boswell W, Postlethwait J, Warren W, Kunz M, Walter RB, Schartl M. Expression signatures of early-stage and advanced medaka melanomas. Comp Biochem Physiol C Toxicol Pharmacol 2018;208:20-8. [PMID: 29162497 DOI: 10.1016/j.cbpc.2017.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
49 Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, Onuchic JN, Levine H. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Front Oncol. 2015;5:155. [PMID: 26258068 DOI: 10.3389/fonc.2015.00155] [Cited by in Crossref: 349] [Cited by in F6Publishing: 331] [Article Influence: 49.9] [Reference Citation Analysis]
50 Saarikangas J, Zhao H, Lappalainen P. Regulation of the actin cytoskeleton-plasma membrane interplay by phosphoinositides. Physiol Rev 2010;90:259-89. [PMID: 20086078 DOI: 10.1152/physrev.00036.2009] [Cited by in Crossref: 332] [Cited by in F6Publishing: 314] [Article Influence: 27.7] [Reference Citation Analysis]
51 Zhang GJ, Zhou T, Tian HP, Liu ZL, Xia SS. High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer. Oncol Lett 2013;5:564-8. [PMID: 23420790 DOI: 10.3892/ol.2012.1026] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
52 Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ, Garcia-Blanco MA. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 2011;9:997-1007. [PMID: 21665936 DOI: 10.1158/1541-7786.MCR-10-0490] [Cited by in Crossref: 452] [Cited by in F6Publishing: 276] [Article Influence: 41.1] [Reference Citation Analysis]
53 Hakomori SI. Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett 2010;584:1901-6. [PMID: 19874824 DOI: 10.1016/j.febslet.2009.10.065] [Cited by in Crossref: 84] [Cited by in F6Publishing: 77] [Article Influence: 6.5] [Reference Citation Analysis]
54 Olsen CJ, Moreira J, Lukanidin EM, Ambartsumian NS. Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts. BMC Cancer 2010;10:444. [PMID: 20723242 DOI: 10.1186/1471-2407-10-444] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 5.5] [Reference Citation Analysis]
55 Mallak AJ, Abbaszadegan MR, Khorasanizadeh PN, Forghanifard MM. Contribution of EVX1 in Aggressiveness of Esophageal Squamous Cell Carcinoma. Pathol Oncol Res 2016;22:341-7. [PMID: 26552663 DOI: 10.1007/s12253-015-0005-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
56 Cannito S, Novo E, di Bonzo LV, Busletta C, Colombatto S, Parola M. Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid Redox Signal. 2010;12:1383-1430. [PMID: 19903090 DOI: 10.1089/ars.2009.2737] [Cited by in Crossref: 156] [Cited by in F6Publishing: 159] [Article Influence: 13.0] [Reference Citation Analysis]
57 Gao X, Cai Y, An R. miR‑215 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer. Int J Mol Med 2018;42:1229-36. [PMID: 29845221 DOI: 10.3892/ijmm.2018.3703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
58 Yuan S, Norgard RJ, Stanger BZ. Cellular Plasticity in Cancer. Cancer Discov 2019;9:837-51. [PMID: 30992279 DOI: 10.1158/2159-8290.CD-19-0015] [Cited by in Crossref: 104] [Cited by in F6Publishing: 57] [Article Influence: 34.7] [Reference Citation Analysis]
59 Uchino M, Kojima H, Wada K, Imada M, Onoda F, Satofuka H, Utsugi T, Murakami Y. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells. BMC Cancer 2010;10:414. [PMID: 20696077 DOI: 10.1186/1471-2407-10-414] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.7] [Reference Citation Analysis]
60 Blick T, Hugo H, Widodo E, Waltham M, Pinto C, Mani SA, Weinberg RA, Neve RM, Lenburg ME, Thompson EW. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia 2010;15:235-52. [PMID: 20521089 DOI: 10.1007/s10911-010-9175-z] [Cited by in Crossref: 197] [Cited by in F6Publishing: 192] [Article Influence: 16.4] [Reference Citation Analysis]
61 Ziaja M, Urbanek KA, Kowalska K, Piastowska-Ciesielska AW. Angiotensin II and Angiotensin Receptors 1 and 2-Multifunctional System in Cells Biology, What Do We Know? Cells 2021;10:381. [PMID: 33673178 DOI: 10.3390/cells10020381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
62 Li Y, Huang S, Li Y, Zhang W, He K, Zhao M, Lin H, Li D, Zhang H, Zheng Z, Huang C. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells. Tumour Biol. 2016;37:14205-14215. [PMID: 27553025 DOI: 10.1007/s13277-016-5254-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
63 Dower CM, Wills CA, Frisch SM, Wang HG. Mechanisms and context underlying the role of autophagy in cancer metastasis. Autophagy 2018;14:1110-28. [PMID: 29863947 DOI: 10.1080/15548627.2018.1450020] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 16.0] [Reference Citation Analysis]
64 He Y, Li L, Liu J, Zhang X. Iodine-125 seed brachytherapy inhibits non–small cell lung cancer by suppressing epithelial-mesenchymal transition. Brachytherapy 2018;17:696-701. [DOI: 10.1016/j.brachy.2018.03.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Yang G, Zhu Z, Wang Y, Gao A, Niu P, Chen L, Tian L. Bone morphogenetic protein 7 attenuates epithelial-mesenchymal transition induced by silica. Hum Exp Toxicol 2016;35:69-77. [PMID: 25733726 DOI: 10.1177/0960327115577550] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
66 Zhang J, Yan Y, Yang Y, Wang L, Li M, Wang J, Liu X, Duan X, Wang J. High Infiltration of Tumor-Associated Macrophages Influences Poor Prognosis in Human Gastric Cancer Patients, Associates With the Phenomenon of EMT. Medicine (Baltimore). 2016;95:e2636. [PMID: 26871785 DOI: 10.1097/md.0000000000002636] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
67 Myoteri D, Dellaportas D, Lykoudis PM, Apostolopoulos A, Marinis A, Zizi-Sermpetzoglou A. Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma. Gastroenterol Res Pract 2017;2017:9207616. [PMID: 28421110 DOI: 10.1155/2017/9207616] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
68 Walen KH. Cell cycle stress in normal human cells: A route to "first cells" (with/without fitness gain) and cancer-like cell-shape changes. Semin Cancer Biol 2021:S1044-579X(21)00001-8. [PMID: 33440246 DOI: 10.1016/j.semcancer.2020.12.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Liu QL, Luo M, Huang C, Chen HN, Zhou ZG. Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy. Front Oncol 2021;11:657546. [PMID: 33996581 DOI: 10.3389/fonc.2021.657546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Carey SP, D'Alfonso TM, Shin SJ, Reinhart-King CA. Mechanobiology of tumor invasion: engineering meets oncology. Crit Rev Oncol Hematol 2012;83:170-83. [PMID: 22178415 DOI: 10.1016/j.critrevonc.2011.11.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
71 Cervantes-Arias A, Pang LY, Argyle DJ. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype. Vet Comp Oncol 2013;11:169-84. [PMID: 22404947 DOI: 10.1111/j.1476-5829.2011.00313.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
72 Ma Q, He J. Enhanced expression of queuine tRNA-ribosyltransferase 1 (QTRT1) predicts poor prognosis in lung adenocarcinoma. Ann Transl Med 2020;8:1658. [PMID: 33490170 DOI: 10.21037/atm-20-7424] [Reference Citation Analysis]
73 Liu X, Li J, Xiong J, Li M, Zhang Y, Zheng Q. Notch-dependent expression of epithelial-mesenchymal transition markers in cholangiocytes after liver transplantation. Hepatol Res. 2012;42:1024-1038. [PMID: 22594800 DOI: 10.1111/j.1872-034X.2012.01011.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
74 Liu J, Li C, Zhang L, Liu K, Jiang X, Wang X, Yang L, Liang W, Liu K, Hu J, Li F. Association of tumour-associated macrophages with cancer cell EMT, invasion, and metastasis of Kazakh oesophageal squamous cell cancer. Diagn Pathol 2019;14:55. [PMID: 31186031 DOI: 10.1186/s13000-019-0834-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
75 Gordon SR. Cell Migration along the Basement Membrane during Wound Repair. The Corneal Endothelium as a Model System. In: Gefen A, editor. Bioengineering Research of Chronic Wounds. Berlin: Springer Berlin Heidelberg; 2009. pp. 43-84. [DOI: 10.1007/978-3-642-00534-3_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
76 Tamkus D, Sikorskii A, Gallo KA, Wiese DA, Leece C, Madhukar BV, Chivu SC, Chitneni S, Dimitrov NV. Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence. ISRN Oncol 2013;2013:385398. [PMID: 23844294 DOI: 10.1155/2013/385398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
77 Hayashida T, Takahashi F, Chiba N, Brachtel E, Takahashi M, Godin-Heymann N, Gross KW, Vivanco Md, Wijendran V, Shioda T, Sgroi D, Donahoe PK, Maheswaran S. HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad Sci U S A 2010;107:1100-5. [PMID: 20080567 DOI: 10.1073/pnas.0912710107] [Cited by in Crossref: 114] [Cited by in F6Publishing: 109] [Article Influence: 8.8] [Reference Citation Analysis]
78 Wang X, Li X, Wang Z. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes. Oncol Rep 2021;45:40. [PMID: 33649837 DOI: 10.3892/or.2021.7991] [Reference Citation Analysis]
79 Minamida S, Iwamura M, Kodera Y, Kawashima Y, Ikeda M, Okusa H, Fujita T, Maeda T, Baba S. Profilin 1 overexpression in renal cell carcinoma. Int J Urol 2011;18:63-71. [PMID: 21091798 DOI: 10.1111/j.1442-2042.2010.02670.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
80 Jiang H, Zhou Z, Jin S, Xu K, Zhang H, Xu J, Sun Q, Wang J, Xu J. PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Sci 2018;109:1414-27. [PMID: 29603830 DOI: 10.1111/cas.13598] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
81 Hernandez P, Tirnauer JS. Tumor suppressor interactions with microtubules: keeping cell polarity and cell division on track. Disease Models & Mechanisms 2010;3:304-15. [DOI: 10.1242/dmm.004507] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
82 Yabusaki N, Yamada S, Murai T, Kanda M, Kobayashi D, Tanaka C, Fujii T, Nakayama G, Sugimoto H, Koike M. Clinical significance of zinc-finger E-box binding homeobox 1 mRNA levels in peritoneal washing for gastric cancer. Mol Clin Oncol. 2015;3:435-441. [PMID: 25798282 DOI: 10.3892/mco.2014.462] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
83 Bhatia S, Wang P, Toh A, Thompson EW. New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression. Front Mol Biosci 2020;7:71. [PMID: 32391381 DOI: 10.3389/fmolb.2020.00071] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
84 Siletz A, Schnabel M, Kniazeva E, Schumacher AJ, Shin S, Jeruss JS, Shea LD. Dynamic transcription factor networks in epithelial-mesenchymal transition in breast cancer models. PLoS One 2013;8:e57180. [PMID: 23593114 DOI: 10.1371/journal.pone.0057180] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
85 Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674. [PMID: 21376230 DOI: 10.1016/j.cell.2011.02.013] [Cited by in Crossref: 33789] [Cited by in F6Publishing: 31247] [Article Influence: 3071.7] [Reference Citation Analysis]
86 Hayashi Y, Molina JR, Hamilton SR, Georgescu MM. NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia 2010;12:1013-22. [PMID: 21170265 DOI: 10.1593/neo.10780] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 5.9] [Reference Citation Analysis]
87 Ochieng J, Nangami GN, Ogunkua O, Miousse IR, Koturbash I, Odero-Marah V, McCawley LJ, Nangia-Makker P, Ahmed N, Luqmani Y, Chen Z, Papagerakis S, Wolf GT, Dong C, Zhou BP, Brown DG, Colacci AM, Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Al-Temaimi R, Al-Mulla F, Bisson WH, Eltom SE. The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis 2015;36 Suppl 1:S128-59. [PMID: 26106135 DOI: 10.1093/carcin/bgv034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
88 Kohrman AQ, Matus DQ. Divide or Conquer: Cell Cycle Regulation of Invasive Behavior. Trends Cell Biol 2017;27:12-25. [PMID: 27634432 DOI: 10.1016/j.tcb.2016.08.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
89 He T, Zhang L, Kong Y, Huang Y, Zhang Y, Zhou D, Zhou X, Yan Y, Zhang L, Lu S, Zhou J, Wang W. Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis. Int J Oncol 2017;51:1722-30. [PMID: 29075788 DOI: 10.3892/ijo.2017.4175] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
90 Yoon S, Li H, Quintanar L, Armstrong B, Rossi JJ. Uncovering Differently Expressed Markers and Heterogeneity on Human Pancreatic Cancer. Transl Oncol 2020;13:100749. [PMID: 32143178 DOI: 10.1016/j.tranon.2020.100749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
91 Gloushankova NA, Rubtsova SN, Zhitnyak IY. Cadherin-mediated cell-cell interactions in normal and cancer cells. Tissue Barriers 2017;5:e1356900. [PMID: 28783415 DOI: 10.1080/21688370.2017.1356900] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
92 Haruyama Y, Kataoka H. Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 275-283 [PMID: 26755876 DOI: 10.3748/wjg.v22.i1.275] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 51] [Article Influence: 9.5] [Reference Citation Analysis]
93 Mahmood MQ, Ward C, Muller HK, Sohal SS, Walters EH. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease. Med Oncol 2017;34:45. [PMID: 28197929 DOI: 10.1007/s12032-017-0900-y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 59] [Article Influence: 10.4] [Reference Citation Analysis]
94 Jézéquel P, Campion L, Spyratos F, Loussouarn D, Campone M, Guérin-Charbonnel C, Joalland MP, André J, Descotes F, Grenot C, Roy P, Carlioz A, Martin PM, Chassevent A, Jourdan ML, Ricolleau G. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study. Int J Cancer 2012;131:426-37. [PMID: 21898387 DOI: 10.1002/ijc.26397] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
95 Shang X, Lin X, Alvarez E, Manorek G, Howell SB. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases. Neoplasia 2012;14:974-85. [PMID: 23097631 DOI: 10.1593/neo.12942] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
96 Bao B, Azmi AS, Ali S, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta. 2012;1826:272-296. [PMID: 22579961 DOI: 10.1016/j.bbcan.2012.04.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 80] [Article Influence: 3.8] [Reference Citation Analysis]
97 Winitthana T, Lawanprasert S, Chanvorachote P. Triclosan potentiates epithelial-to-mesenchymal transition in anoikis-resistant human lung cancer cells. PLoS One 2014;9:e110851. [PMID: 25329306 DOI: 10.1371/journal.pone.0110851] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
98 Lee P, Li X. Expression Profiles of the Phosphatase and Tensin Homolog (PTEN), CDH1, and CDH2 Genes, and the Cell Membrane Protein, CD133, in the Ishikawa Human Endometrial Adenocarcinoma Cell Line. Med Sci Monit 2019;25:9829-35. [PMID: 31864232 DOI: 10.12659/MSM.918787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
99 Li A, Omura N, Hong SM, Vincent A, Walter K, Griffith M, Borges M, Goggins M. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res 2010;70:5226-37. [PMID: 20551052 DOI: 10.1158/0008-5472.CAN-09-4227] [Cited by in Crossref: 203] [Cited by in F6Publishing: 137] [Article Influence: 16.9] [Reference Citation Analysis]
100 Li S, Cong X, Gao H, Lan X, Li Z, Wang W, Song S, Wang Y, Li C, Zhang H, Zhao Y, Xue Y. Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells. J Exp Clin Cancer Res 2019;38:6. [PMID: 30616627 DOI: 10.1186/s13046-018-1003-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 11.7] [Reference Citation Analysis]
101 Zhang H, Li S, Xu H, Sun L, Zhu Z, Yao Z. Interference of miR-107 with Atg12 is inhibited by HULC to promote metastasis of hepatocellular carcinoma. MedComm (2020) 2020;1:165-77. [PMID: 34766115 DOI: 10.1002/mco2.25] [Reference Citation Analysis]
102 Bell RE, Levy C. The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. Pigment Cell Melanoma Res 2011;24:1088-106. [PMID: 22004179 DOI: 10.1111/j.1755-148X.2011.00931.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
103 Witte MH, Dellinger MT, Papendieck CM, Boccardo F. Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia. Clin Exp Metastasis 2012;29:707-27. [PMID: 22798218 DOI: 10.1007/s10585-012-9493-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
104 Xing J, Tian XJ. Investigating epithelial-to-mesenchymal transition with integrated computational and experimental approaches. Phys Biol 2019;16:031001. [PMID: 30665206 DOI: 10.1088/1478-3975/ab0032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
105 Klymkowsky MW, Rossi CC, Artinger KB. Mechanisms driving neural crest induction and migration in the zebrafish and Xenopus laevis. Cell Adh Migr 2010;4:595-608. [PMID: 20962584 DOI: 10.4161/cam.4.4.12962] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
106 Azmi AS, Bollig-Fischer A, Bao B, Park BJ, Lee SH, Yong-Song G, Dyson G, Reddy CK, Sarkar FH, Mohammad RM. Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25. BMC Syst Biol 2013;7:85. [PMID: 24004452 DOI: 10.1186/1752-0509-7-85] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
107 Zhang Y, Cai H, Liao Y, Zhu Y, Wang F, Hou J. Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathway. Int J Oncol 2020;57:743-55. [PMID: 32705252 DOI: 10.3892/ijo.2020.5083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
108 Faratian D, Christiansen J, Gustavson M, Jones C, Scott C, Um I, Harrison DJ. Heterogeneity mapping of protein expression in tumors using quantitative immunofluorescence. J Vis Exp 2011;:e3334. [PMID: 22064683 DOI: 10.3791/3334] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
109 Scoazec JY. [Epithelial-mesenchymal transition and colon cancer]. Ann Pathol 2009;29 Spec No 1:S63-4. [PMID: 19887255 DOI: 10.1016/j.annpat.2009.07.037] [Reference Citation Analysis]
110 Okubo S, Mitsunaga S, Kato Y, Kojima M, Sugimoto M, Gotohda N, Takahashi S, Hayashi R, Konishi M. The prognostic impact of differentiation at the invasive front of biliary tract cancer. J Surg Oncol 2018;117:1278-87. [DOI: 10.1002/jso.24946] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
111 Yan W, Wu K, Herman JG, Brock MV, Zhou Y, Lu Y, Zhang Z, Yang Y, Guo M. Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling. J Cell Mol Med 2014;18:2499-511. [PMID: 24912879 DOI: 10.1111/jcmm.12325] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
112 Jie XX, Zhang XY, Xu CJ. Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications. Oncotarget 2017;8:81558-71. [PMID: 29113414 DOI: 10.18632/oncotarget.18277] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 17.8] [Reference Citation Analysis]
113 Takeyama Y, Sato M, Horio M, Hase T, Yoshida K, Yokoyama T, Nakashima H, Hashimoto N, Sekido Y, Gazdar AF, Minna JD, Kondo M, Hasegawa Y. Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Lett 2010;296:216-24. [PMID: 20452118 DOI: 10.1016/j.canlet.2010.04.008] [Cited by in Crossref: 102] [Cited by in F6Publishing: 105] [Article Influence: 8.5] [Reference Citation Analysis]
114 Thurston SF, Kulacz WA, Shaikh S, Lee JM, Copeland JW. The ability to induce microtubule acetylation is a general feature of formin proteins. PLoS One. 2012;7:e48041. [PMID: 23110170 DOI: 10.1371/journal.pone.0048041] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
115 Su Z, Li G, Liu C, Ren S, Deng T, Zhang S, Tian Y, Liu Y, Qiu Y. Autophagy inhibition impairs the epithelial-mesenchymal transition and enhances cisplatin sensitivity in nasopharyngeal carcinoma. Oncol Lett 2017;13:4147-54. [PMID: 28599416 DOI: 10.3892/ol.2017.5963] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
116 Miller SJ, Lan ZD, Hardiman A, Wu J, Kordich JJ, Patmore DM, Hegde RS, Cripe TP, Cancelas JA, Collins MH, Ratner N. Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis. Oncogene 2010;29:368-79. [PMID: 19901965 DOI: 10.1038/onc.2009.360] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
117 Terry S, El-Sayed IY, Destouches D, Maillé P, Nicolaiew N, Ploussard G, Semprez F, Pimpie C, Beltran H, Londono-Vallejo A, Allory Y, de la Taille A, Salomon DS, Vacherot F. CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities. Oncotarget 2015;6:11994-2008. [PMID: 25596738 DOI: 10.18632/oncotarget.2740] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
118 Sarkar A, Sengupta S, Mukherjee A, Chatterjee J. Fourier transform infra-red spectroscopic signatures for lung cells' epithelial mesenchymal transition: A preliminary report. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2017;173:809-16. [DOI: 10.1016/j.saa.2016.10.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
119 Zhang L, Wang X, Chen P. MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells. BMC Cancer. 2013;13:290. [PMID: 23768087 DOI: 10.1186/1471-2407-13-290] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 9.9] [Reference Citation Analysis]
120 Coban B, Bergonzini C, Zweemer AJM, Danen EHJ. Metastasis: crosstalk between tissue mechanics and tumour cell plasticity. Br J Cancer 2021;124:49-57. [PMID: 33204023 DOI: 10.1038/s41416-020-01150-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
121 Handra-Luca A, Hong SM, Walter K, Wolfgang C, Hruban R, Goggins M. Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas. Br J Cancer. 2011;104:1296-1302. [PMID: 21448168 DOI: 10.1038/bjc.2011.93] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
122 Maseki S, Ijichi K, Tanaka H, Fujii M, Hasegawa Y, Ogawa T, Murakami S, Kondo E, Nakanishi H. Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway. Br J Cancer. 2012;106:1196-1204. [PMID: 22315058 DOI: 10.1038/bjc.2012.24] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 8.3] [Reference Citation Analysis]
123 Nassour M, Idoux-Gillet Y, Selmi A, Côme C, Faraldo ML, Deugnier MA, Savagner P. Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis. PLoS One 2012;7:e53498. [PMID: 23300933 DOI: 10.1371/journal.pone.0053498] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 6.5] [Reference Citation Analysis]
124 Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703-719. [PMID: 22664915 DOI: 10.4161/rna.20481] [Cited by in Crossref: 1110] [Cited by in F6Publishing: 1143] [Article Influence: 111.0] [Reference Citation Analysis]
125 da Fonseca LM, da Silva VA, Freire-de-Lima L, Previato JO, Mendonça-Previato L, Capella MA. Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition? Front Oncol 2016;6:158. [PMID: 27446804 DOI: 10.3389/fonc.2016.00158] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
126 Ren J, Chen Y, Song H, Chen L, Wang R. Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line. J Cell Biochem 2013;114:1395-403. [DOI: 10.1002/jcb.24481] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 7.7] [Reference Citation Analysis]
127 Sung R, Lee SH, Ji M, Han JH, Kang MH, Kim JH, Choi JW, Kim YC, Park SM. Epithelial-mesenchymal transition-related protein expression in biliary epithelial cells associated with hepatolithiasis. J Gastroenterol Hepatol. 2014;29:395-402. [PMID: 23927024 DOI: 10.1111/jgh.12349] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
128 Kashikar ND, Reiner J, Datta A, Datta PK. Serine threonine receptor-associated protein (STRAP) plays a role in the maintenance of mesenchymal morphology. Cell Signal 2010;22:138-49. [PMID: 19781628 DOI: 10.1016/j.cellsig.2009.09.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
129 Liu Y, Du F, Chen W, Yao M, Lv K, Fu P. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin. Experimental Cell Research 2013;319:3140-9. [DOI: 10.1016/j.yexcr.2013.08.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
130 Ding L, Lu Z, Lu Q, Chen YH. The claudin family of proteins in human malignancy: A clinical perspective. Cancer Manag Res. 2013;5:367-375. [PMID: 24232410 DOI: 10.2147/cmar.s38294] [Cited by in Crossref: 12] [Cited by in F6Publishing: 46] [Article Influence: 1.3] [Reference Citation Analysis]
131 Shu J, Wang L, Han F, Chen Y, Wang S, Luo F. BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer. Biomed Res Int 2019;2019:5937635. [PMID: 31886230 DOI: 10.1155/2019/5937635] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
132 Lamouille S, Derynck R. Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition. Cells Tissues Organs. 2011;193:8-22. [PMID: 21041997 DOI: 10.1159/000320172] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
133 Shi J, Severson C, Yang J, Wedlich D, Klymkowsky MW. Snail2 controls mesodermal BMP/Wnt induction of neural crest. Development 2011;138:3135-45. [PMID: 21715424 DOI: 10.1242/dev.064394] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
134 Abba ML, Patil N, Leupold JH, Allgayer H. MicroRNA Regulation of Epithelial to Mesenchymal Transition. J Clin Med 2016;5:E8. [PMID: 26784241 DOI: 10.3390/jcm5010008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
135 Sato Y, Harada K, Itatsu K, Ikeda H, Kakuda Y, Shimomura S, Shan Ren X, Yoneda N, Sasaki M, Nakanuma Y. Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma. Am J Pathol. 2010;177:141-152. [PMID: 20489148 DOI: 10.2353/ajpath.2010.090747] [Cited by in Crossref: 63] [Cited by in F6Publishing: 112] [Article Influence: 5.3] [Reference Citation Analysis]
136 Waldmeier L, Meyer-Schaller N, Diepenbruck M, Christofori G. Py2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivo. PLoS One 2012;7:e48651. [PMID: 23144919 DOI: 10.1371/journal.pone.0048651] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
137 Xu K, Mao X, Mehta M, Cui J, Zhang C, Xu Y. A comparative study of gene-expression data of basal cell carcinoma and melanoma reveals new insights about the two cancers. PLoS One 2012;7:e30750. [PMID: 22295108 DOI: 10.1371/journal.pone.0030750] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
138 Bidarra SJ, Oliveira P, Rocha S, Saraiva DP, Oliveira C, Barrias CC. A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion. Sci Rep 2016;6:27072. [PMID: 27255191 DOI: 10.1038/srep27072] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
139 Ziegler YS, Moresco JJ, Tu PG, Yates JR 3rd, Nardulli AM. Plasma membrane proteomics of human breast cancer cell lines identifies potential targets for breast cancer diagnosis and treatment. PLoS One 2014;9:e102341. [PMID: 25029196 DOI: 10.1371/journal.pone.0102341] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
140 Dos Santos A, Court M, Thiers V, Sar S, Guettier C, Samuel D, Bréchot C, Garin J, Demaugre F, Masselon CD. Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics. Mol Cell Proteomics 2010;9:1991-2004. [PMID: 20513801 DOI: 10.1074/mcp.M110.000026] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
141 Barrière G, Tartary M, Rigaud M. Epithelial mesenchymal transition: a new insight into the detection of circulating tumor cells. ISRN Oncol 2012;2012:382010. [PMID: 22577580 DOI: 10.5402/2012/382010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
142 Wudtiwai B, Pitchakarn P, Banjerdpongchai R. Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells. Toxicol In Vitro 2018;53:222-32. [PMID: 30195041 DOI: 10.1016/j.tiv.2018.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
143 Citro S, Bellini A, Miccolo C, Ghiani L, Carey TE, Chiocca S. Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α. Br J Cancer 2019;120:658-67. [PMID: 30765872 DOI: 10.1038/s41416-019-0394-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
144 Xu K, Liu L, Wu K, Zhang M, Xie R, Li R, Zhao M, Yang H, Duan N, Wang X, Wang W. Altered protein profile of plasma extracellular vesicles in oral squamous cell carcinoma development. J Proteomics 2022;251:104422. [PMID: 34775099 DOI: 10.1016/j.jprot.2021.104422] [Reference Citation Analysis]
145 Huo TX, Wang XP, Yu Z, Kong B, He Y, Guo QL, Zhang XB, Qiang L. Oroxylin A inhibits the migration of hepatocellular carcinoma cells by inducing NAG-1 expression. Acta Pharmacol Sin 2021. [PMID: 34117368 DOI: 10.1038/s41401-021-00695-4] [Reference Citation Analysis]
146 Bai WD, Ye XM, Zhang MY, Zhu HY, Xi WJ, Huang X, Zhao J, Gu B, Zheng GX, Yang AG, Jia LT. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. Int J Cancer 2014;135:1356-68. [PMID: 24615544 DOI: 10.1002/ijc.28782] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 12.4] [Reference Citation Analysis]
147 Nilsson GM, Akhtar N, Kannius-Janson M, Baeckström D. Loss of E-cadherin expression is not a prerequisite for c-erbB2-induced epithelial-mesenchymal transition. Int J Oncol 2014;45:82-94. [PMID: 24807161 DOI: 10.3892/ijo.2014.2424] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
148 Jin YL, Xin LM, Zhou CC, Ren Y. Polydatin exerts anti-tumor effects against renal cell carcinoma cells via induction of caspase-dependent apoptosis and inhibition of the PI3K/Akt pathway. Onco Targets Ther 2018;11:8185-95. [PMID: 30532558 DOI: 10.2147/OTT.S180785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
149 May CD, Sphyris N, Evans KW, Werden SJ, Guo W, Mani SA. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 2011;13:202. [PMID: 21392411 DOI: 10.1186/bcr2789] [Cited by in Crossref: 218] [Cited by in F6Publishing: 220] [Article Influence: 19.8] [Reference Citation Analysis]
150 Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, Mani SA, Pienta KJ, Ben-Jacob E, Levine H. Stability of the hybrid epithelial/mesenchymal phenotype. Oncotarget. 2016;7:27067-27084. [PMID: 27008704 DOI: 10.18632/oncotarget.8166] [Cited by in Crossref: 234] [Cited by in F6Publishing: 202] [Article Influence: 46.8] [Reference Citation Analysis]
151 Baulida J, García de Herreros A. Snail1-driven plasticity of epithelial and mesenchymal cells sustains cancer malignancy. Biochim Biophys Acta 2015;1856:55-61. [PMID: 26050961 DOI: 10.1016/j.bbcan.2015.05.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
152 Zhou HM, Dong TT, Wang LL, Feng B, Zhao HC, Fan XK, Zheng MH. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition. World J Gastroenterol 2012; 18(21): 2640-2648 [PMID: 22690072 DOI: 10.3748/wjg.v18.i21.2640] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
153 Kim J, Hwan Kim S. CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells. PLoS One 2013;8:e74342. [PMID: 24023938 DOI: 10.1371/journal.pone.0074342] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
154 Bornes L, Belthier G, van Rheenen J. Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States. J Clin Med 2021;10:2403. [PMID: 34072345 DOI: 10.3390/jcm10112403] [Reference Citation Analysis]
155 Ogbu SC, Musich PR, Zhang J, Yao ZQ, Howe PH, Jiang Y. The role of disabled-2 (Dab2) in diseases. Gene 2021;769:145202. [PMID: 33059028 DOI: 10.1016/j.gene.2020.145202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
156 Takakura M, Kyo S, Nakamura M, Maida Y, Mizumoto Y, Bono Y, Zhang X, Hashimoto Y, Urata Y, Fujiwara T, Inoue M. Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers. Br J Cancer 2012;107:448-54. [PMID: 22735905 DOI: 10.1038/bjc.2012.276] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
157 Salviano-Silva A, Berti FCB, Lobo-Alves SC, de Araujo-Souza PS, Boldt ABW, Malheiros D. Interaction of Long Noncoding RNAs and Notch Signaling: Implications for Tissue Homeostasis Loss. Adv Exp Med Biol 2020;1227:107-29. [PMID: 32072502 DOI: 10.1007/978-3-030-36422-9_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Mathias RA, Gopal SK, Simpson RJ. Contribution of cells undergoing epithelial–mesenchymal transition to the tumour microenvironment. Journal of Proteomics 2013;78:545-57. [DOI: 10.1016/j.jprot.2012.10.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
159 Chen C, Liang QY, Chen HK, Wu PF, Feng ZY, Ma XM, Wu HR, Zhou GQ. DRAM1 regulates the migration and invasion of hepatoblastoma cells via autophagy-EMT pathway. Oncol Lett 2018;16:2427-33. [PMID: 30013633 DOI: 10.3892/ol.2018.8937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
160 Du F, Nakamura Y, Tan TL, Lee P, Lee R, Yu B, Jamora C. Expression of snail in epidermal keratinocytes promotes cutaneous inflammation and hyperplasia conducive to tumor formation. Cancer Res 2010;70:10080-9. [PMID: 21159631 DOI: 10.1158/0008-5472.CAN-10-0324] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
161 Mato E, González C, Moral A, Pérez JI, Bell O, Lerma E, de Leiva A. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1). J Mol Endocrinol 2014;52:289-300. [PMID: 24643400 DOI: 10.1530/JME-14-0051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
162 Cambados N, Walther T, Nahmod K, Tocci JM, Rubinstein N, Böhme I, Simian M, Sampayo R, Del Valle Suberbordes M, Kordon EC, Schere-Levy C. Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells. Oncotarget 2017;8:88475-87. [PMID: 29179450 DOI: 10.18632/oncotarget.19290] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
163 Quarta S, Vidalino L, Turato C, Ruvoletto M, Calabrese F, Valente M, Cannito S, Fassina G, Parola M, Gatta A, Pontisso P. SERPINB3 induces epithelial-mesenchymal transition. J Pathol. 2010;221:343-356. [PMID: 20527027 DOI: 10.1002/path.2708] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 5.2] [Reference Citation Analysis]
164 Wang B, Xia YJ, Yan W, Xia LM, Tian DA. Influence of hypoxia-induced epithelial-mesenchymal transition on side population cells in hepatocellular carcinoma cell line SMMC-7721. Shijie Huaren Xiaohua Zazhi 2010; 18(26): 2750-2755 [DOI: 10.11569/wcjd.v18.i26.2750] [Reference Citation Analysis]
165 Kumar S, Park SH, Cieply B, Schupp J, Killiam E, Zhang F, Rimm DL, Frisch SM. A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Mol Cell Biol 2011;31:4036-51. [PMID: 21746881 DOI: 10.1128/MCB.01342-10] [Cited by in Crossref: 90] [Cited by in F6Publishing: 60] [Article Influence: 8.2] [Reference Citation Analysis]
166 Shi J, Zhang H, Dowell RD, Klymkowsky MW. sizzled function and secreted factor network dynamics. Biol Open 2012;1:286-94. [PMID: 23213419 DOI: 10.1242/bio.2012019] [Reference Citation Analysis]
167 Takano H, Takumi S, Ikema S, Mizoue N, Hotta Y, Shiozaki K, Sugiyama Y, Furukawa T, Komatsu M. Microcystin-LR induces anoikis resistance to the hepatocyte uptake transporter OATP1B3-expressing cell lines. Toxicology 2014;326:53-61. [DOI: 10.1016/j.tox.2014.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
168 Jiang YJ, Bikle DD. LncRNA: a new player in 1α, 25(OH)(2) vitamin D(3) /VDR protection against skin cancer formation. Exp Dermatol 2014;23:147-50. [PMID: 24499465 DOI: 10.1111/exd.12341] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
169 Roxanis I. Occurrence and significance of epithelial-mesenchymal transition in breast cancer. J Clin Pathol 2013;66:517-21. [PMID: 23322823 DOI: 10.1136/jclinpath-2012-201348] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
170 Cornelison R, Marrah L, Horter D, Lynch S, Li H. Targeting AVIL, a New Cytoskeleton Regulator in Glioblastoma. IJMS 2021;22:13635. [DOI: 10.3390/ijms222413635] [Reference Citation Analysis]
171 Zhang S, Che D, Yang F, Chi C, Meng H, Shen J, Qi L, Liu F, Lv L, Li Y, Meng Q, Liu J, Shang L, Yu Y. Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer. Oncotarget 2017;8:99801-15. [PMID: 29245941 DOI: 10.18632/oncotarget.21068] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 8.2] [Reference Citation Analysis]
172 Bhat K, Sarkissyan M, Wu Y, Vadgama JV. GROα overexpression drives cell migration and invasion in triple negative breast cancer cells. Oncol Rep 2017;38:21-30. [PMID: 28560447 DOI: 10.3892/or.2017.5668] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
173 Driesen RB, Hilkens P, Smisdom N, Vangansewinkel T, Dillen Y, Ratajczak J, Wolfs E, Gervois P, Ameloot M, Bronckaers A, Lambrichts I. Dental Tissue and Stem Cells Revisited: New Insights From the Expression of Fibroblast Activation Protein-Alpha. Front Cell Dev Biol 2019;7:389. [PMID: 32039205 DOI: 10.3389/fcell.2019.00389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
174 de Herreros AG, Peiró S, Nassour M, Savagner P. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia. 2010;15:135-147. [PMID: 20455012 DOI: 10.1007/s10911-010-9179-8] [Cited by in Crossref: 164] [Cited by in F6Publishing: 161] [Article Influence: 13.7] [Reference Citation Analysis]
175 Zheng S, Chen H, Wang Y, Gao W, Fu Z, Zhou Q, Jiang Y, Lin Q, Tan L, Ye H, Zhao X, Luo Y, Li G, Ye L, Liu Y, Li W, Li Z, Chen R. Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner. Cancer Lett 2016;371:354-65. [PMID: 26708505 DOI: 10.1016/j.canlet.2015.12.010] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
176 Gunasinghe NP, Wells A, Thompson EW, Hugo HJ. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev 2012;31:469-78. [PMID: 22729277 DOI: 10.1007/s10555-012-9377-5] [Cited by in Crossref: 216] [Cited by in F6Publishing: 215] [Article Influence: 24.0] [Reference Citation Analysis]
177 Liberko M, Kolostova K, Bobek V. Essentials of circulating tumor cells for clinical research and practice. Crit Rev Oncol Hematol. 2013;88:338-356. [PMID: 23830807 DOI: 10.1016/j.critrevonc.2013.05.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
178 Wang W, Zhang R, Wang X, Wang N, Zhao J, Wei Z, Xiang F, Wang C. Suppression of KIF3A inhibits triple negative breast cancer growth and metastasis by repressing Rb-E2F signaling and epithelial-mesenchymal transition. Cancer Sci 2020;111:1422-34. [PMID: 32011034 DOI: 10.1111/cas.14324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
179 Zha H, Li X, Sun H, Duan L, Yuan S, Li H, Li A, Gu Y, Zhao J, Xie J, Zhou L. S100A9 promotes the proliferation and migration of cervical cancer cells by inducing epithelial‑mesenchymal transition and activating the Wnt/β‑catenin pathway. Int J Oncol 2019;55:35-44. [PMID: 31059008 DOI: 10.3892/ijo.2019.4793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
180 Mao Y, Zhang N, Xu J, Ding Z, Zong R, Liu Z. Significance of heterogeneous Twist2 expression in human breast cancers. PLoS One 2012;7:e48178. [PMID: 23133563 DOI: 10.1371/journal.pone.0048178] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
181 Yu C, Liu Q, Chen C, Yu J, Wang J. Landscape perspectives of tumor, EMT, and development. Phys Biol 2019;16:051003. [PMID: 31067516 DOI: 10.1088/1478-3975/ab2029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
182 Forghanifard MM, Moaven O, Farshchian M, Montazer M, Raeisossadati R, Abdollahi A, Moghbeli M, Nejadsattari T, Parivar K, Abbaszadegan MR. Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis. Ann Surg Oncol 2012;19:743-9. [PMID: 22006371 DOI: 10.1245/s10434-011-2074-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
183 Dubois-marshall S, Thomas JS, Faratian D, Harrison DJ, Katz E. Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer. Clin Exp Metastasis 2011;28:811-8. [DOI: 10.1007/s10585-011-9412-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
184 Castilla MÁ, Díaz-Martín J, Sarrió D, Romero-Pérez L, López-García MÁ, Vieites B, Biscuola M, Ramiro-Fuentes S, Isacke CM, Palacios J. MicroRNA-200 family modulation in distinct breast cancer phenotypes. PLoS One 2012;7:e47709. [PMID: 23112837 DOI: 10.1371/journal.pone.0047709] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 6.8] [Reference Citation Analysis]
185 Futterman MA, García AJ, Zamir EA. Evidence for partial epithelial-to-mesenchymal transition (pEMT) and recruitment of motile blastoderm edge cells during avian epiboly. Dev Dyn 2011;240:1502-11. [PMID: 21412939 DOI: 10.1002/dvdy.22607] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
186 Xie X, Zhu H, Zhang J, Wang M, Zhu L, Guo Z, Shen W, Wang D. Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition. Oncol Lett 2017;14:447-52. [PMID: 28693190 DOI: 10.3892/ol.2017.6147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
187 Li T, Li M, Hu S, Cheng X, Gao Y, Jiang S, Yu Q, Zhang C, Sun P, Xian W, Song Z, Zhang Y, Zheng Q. MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1. Int J Biol Macromol. 2017;103:1054-1061. [PMID: 28539268 DOI: 10.1016/j.ijbiomac.2017.05.108] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
188 Zhu Q, Li Y, Dong X, Yang Y, Wang H, Guo S. Linc-OIP5 loss regulates migration and invasion in MDA-MB-231 breast cancer cells by inhibiting YAP1/JAG1 signaling. Oncol Lett 2020;19:103-12. [PMID: 31897120 DOI: 10.3892/ol.2019.11071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
189 Hu C, Meiners S, Lukas C, Stathopoulos GT, Chen J. Role of exosomal microRNAs in lung cancer biology and clinical applications. Cell Prolif 2020;53:e12828. [PMID: 32391938 DOI: 10.1111/cpr.12828] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
190 Huang M, Wang Y, Zhu L, Cai Q, Li H, Yang H. MAPK pathway mediates epithelial-mesenchymal transition induced by paraquat in alveolar epithelial cells: MAPK Pathway Mediates EMT Induced by Pq in Alveolar Epithelial Cells. Environ Toxicol 2016;31:1407-14. [DOI: 10.1002/tox.22146] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
191 Kim M, Choe S. BMPs and their clinical potentials. BMB Rep. 2011;44:619-634. [PMID: 22026995 DOI: 10.5483/BMBRep.2011.44.10.619] [Cited by in Crossref: 54] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
192 Okugawa Y, Toiyama Y, Tanaka K, Matsusita K, Fujikawa H, Saigusa S, Ohi M, Inoue Y, Mohri Y, Uchida K. Clinical significance of Zinc finger E-box Binding homeobox 1 (ZEB1) in human gastric cancer. J Surg Oncol. 2012;106:280-285. [PMID: 22095522 DOI: 10.1002/jso.22142] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
193 Li J, Yang B, Zhou Q, Wu Y, Shang D, Guo Y, Song Z, Zheng Q, Xiong J. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Carcinogenesis. 2013;34:1343-1351. [PMID: 23430956 DOI: 10.1093/carcin/bgt063] [Cited by in Crossref: 168] [Cited by in F6Publishing: 162] [Article Influence: 18.7] [Reference Citation Analysis]
194 Bhatia S, Monkman J, Toh AKL, Nagaraj SH, Thompson EW. Targeting epithelial-mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring. Biochem J 2017;474:3269-306. [PMID: 28931648 DOI: 10.1042/BCJ20160782] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
195 Byun JS, Gardner K. Wounds that will not heal: pervasive cellular reprogramming in cancer. Am J Pathol 2013;182:1055-64. [PMID: 23438473 DOI: 10.1016/j.ajpath.2013.01.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
196 Shi Y, Wu H, Zhang M, Ding L, Meng F, Fan X. Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol 2013;8:89. [PMID: 23706092 DOI: 10.1186/1746-1596-8-89] [Cited by in Crossref: 46] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
197 Francart ME, Lambert J, Vanwynsberghe AM, Thompson EW, Bourcy M, Polette M, Gilles C. Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases. Dev Dyn 2018;247:432-50. [PMID: 28407379 DOI: 10.1002/dvdy.24506] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 12.0] [Reference Citation Analysis]
198 Wang Z, Li Y, Sarkar FH. Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression. Curr Stem Cell Res Ther. 2010;5:74-80. [PMID: 19951255 DOI: 10.2174/157488810790442813] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 5.3] [Reference Citation Analysis]
199 Steinway SN, Zañudo JGT, Michel PJ, Feith DJ, Loughran TP, Albert R. Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypes. NPJ Syst Biol Appl 2015;1:15014. [PMID: 28725463 DOI: 10.1038/npjsba.2015.14] [Cited by in Crossref: 77] [Cited by in F6Publishing: 52] [Article Influence: 11.0] [Reference Citation Analysis]
200 Feltrin FDS, Agner T, Sayer C, Lona LMF. Curcumin encapsulation in functional PLGA nanoparticles: A promising strategy for cancer therapies. Adv Colloid Interface Sci 2021;300:102582. [PMID: 34953375 DOI: 10.1016/j.cis.2021.102582] [Reference Citation Analysis]
201 Yang C, Cao M, Liu Y, He Y, Du Y, Zhang G, Gao F. Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas. Oncogene 2019;38:7113-32. [PMID: 31417182 DOI: 10.1038/s41388-019-0899-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
202 Kasioumi P, Vrazeli P, Vezyraki P, Zerikiotis S, Katsouras C, Damalas A, Angelidis C. Hsp70 (HSP70A1A) downregulation enhances the metastatic ability of cancer cells. Int J Oncol 2019;54:821-32. [PMID: 30569142 DOI: 10.3892/ijo.2018.4666] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
203 Sivasudhan E, Blake N, Lu ZL, Meng J, Rong R. Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:642443. [PMID: 33869193 DOI: 10.3389/fcell.2021.642443] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
204 Okugawa Y, Inoue Y, Tanaka K, Kawamura M, Saigusa S, Toiyama Y, Ohi M, Uchida K, Mohri Y, Kusunoki M. Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancer. Clin Exp Metastasis. 2013;30:417-429. [PMID: 23143680 DOI: 10.1007/s10585-012-9547-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
205 Pettee KM, Dvorak KM, Nestor-Kalinoski AL, Eisenmann KM. An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids. PLoS One 2014;9:e90371. [PMID: 24587343 DOI: 10.1371/journal.pone.0090371] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
206 Douchi D, Ohtsuka H, Ariake K, Masuda K, Kawasaki S, Kawaguchi K, Fukase K, Oikawa M, Motoi F, Naitoh T, Katayose Y, Egawa S, Unno M. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway. Cancer Lett 2015;365:132-40. [PMID: 26047573 DOI: 10.1016/j.canlet.2015.05.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
207 de Herreros AG, Peiró S, Nassour M, Savagner P. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia 2010;15:135-47. [PMID: 20455012 DOI: 10.1007/s10911-010-9179-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
208 Yamben IF, Rachel RA, Shatadal S, Copeland NG, Jenkins NA, Warming S, Griep AE. Scrib is required for epithelial cell identity and prevents epithelial to mesenchymal transition in the mouse. Dev Biol 2013;384:41-52. [PMID: 24095903 DOI: 10.1016/j.ydbio.2013.09.027] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
209 Mills SC, Goh PH, Kudatsih J, Ncube S, Gurung R, Maxwell W, Mueller A. Cell migration towards CXCL12 in leukemic cells compared to breast cancer cells. Cellular Signalling 2016;28:316-24. [DOI: 10.1016/j.cellsig.2016.01.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
210 Puls TJ, Tan X, Whittington CF, Voytik-Harbin SL. 3D collagen fibrillar microstructure guides pancreatic cancer cell phenotype and serves as a critical design parameter for phenotypic models of EMT. PLoS One 2017;12:e0188870. [PMID: 29190794 DOI: 10.1371/journal.pone.0188870] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
211 Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao L, Li R, Zhao QD, Yang Y, Lu ZH. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett. 2014;352:160-168. [PMID: 24892648 DOI: 10.1016/j.canlet.2014.05.008] [Cited by in Crossref: 228] [Cited by in F6Publishing: 212] [Article Influence: 28.5] [Reference Citation Analysis]
212 Hirakawa S, Detmar M, Kerjaschki D, Nagamatsu S, Matsuo K, Tanemura A, Kamata N, Higashikawa K, Okazaki H, Kameda K, Nishida-Fukuda H, Mori H, Hanakawa Y, Sayama K, Shirakata Y, Tohyama M, Tokumaru S, Katayama I, Hashimoto K. Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease. Am J Pathol 2009;175:2235-48. [PMID: 19815713 DOI: 10.2353/ajpath.2009.090420] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
213 Kim YJ, Koo GB, Lee JY, Moon HS, Kim DG, Lee DG, Lee JY, Oh JH, Park JM, Kim MS, Woo HG, Kim SI, Kang P, Choi W, Sim TS, Park WY, Lee JG, Kim YS. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads. Biomaterials 2014;35:7501-10. [PMID: 24917030 DOI: 10.1016/j.biomaterials.2014.05.039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
214 Gloushankova NA, Rubtsova SN, Zhitnyak IY. An In Vitro System to Study the Epithelial-Mesenchymal Transition In Vitro. Methods Mol Biol 2018;1749:29-42. [PMID: 29525988 DOI: 10.1007/978-1-4939-7701-7_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
215 Wang C, Wang C, Wei Z, Li Y, Wang W, Li X, Zhao J, Zhou X, Qu X, Xiang F. Suppression of motor protein KIF3C expression inhibits tumor growth and metastasis in breast cancer by inhibiting TGF-β signaling. Cancer Lett. 2015;368:105-114. [PMID: 26272184 DOI: 10.1016/j.canlet.2015.07.037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
216 Jolly MK, Ware KE, Gilja S, Somarelli JA, Levine H. EMT and MET: necessary or permissive for metastasis? Mol Oncol 2017;11:755-69. [PMID: 28548345 DOI: 10.1002/1878-0261.12083] [Cited by in Crossref: 169] [Cited by in F6Publishing: 152] [Article Influence: 33.8] [Reference Citation Analysis]
217 Tan J, Zhang X, Xiao W, Liu X, Li C, Guo Y, Xiong W, Li Y. N3ICD with the transmembrane domain can effectively inhibit EMT by correcting the position of tight/adherens junctions. Cell Adh Migr 2019;13:203-18. [PMID: 31096822 DOI: 10.1080/19336918.2019.1619958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
218 Subirá D, Simó M, Illán J, Serrano C, Castañón S, Gonzalo R, Granizo JJ, Martínez-García M, Navarro M, Pardo J, Bruna J. Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis. Clin Exp Metastasis 2015;32:383-91. [PMID: 25795393 DOI: 10.1007/s10585-015-9716-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
219 Porther N, Barbieri MA. The role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cells. Small GTPases 2015;6:135-44. [PMID: 26317377 DOI: 10.1080/21541248.2015.1050152] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
220 Ishii G, Hashimoto H, Atsumi N, Hoshino A, Ochiai A. Morphophenotype of floating colonies derived from a single cancer cell has a critical impact on tumor-forming activity. Pathol Int 2013;63:29-36. [PMID: 23356223 DOI: 10.1111/pin.12018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
221 Ribeiro AS, Paredes J. P-Cadherin Linking Breast Cancer Stem Cells and Invasion: A Promising Marker to Identify an "Intermediate/Metastable" EMT State. Front Oncol 2014;4:371. [PMID: 25601904 DOI: 10.3389/fonc.2014.00371] [Cited by in Crossref: 36] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
222 Kothari AN, Mi Z, Zapf M, Kuo PC. Novel clinical therapeutics targeting the epithelial to mesenchymal transition. Clin Transl Med 2014;3:35. [PMID: 25343018 DOI: 10.1186/s40169-014-0035-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
223 Schneider D, Tarantola M, Janshoff A. Dynamics of TGF-β induced epithelial-to-mesenchymal transition monitored by Electric Cell-Substrate Impedance Sensing. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011;1813:2099-107. [DOI: 10.1016/j.bbamcr.2011.07.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
224 Wishahi M, Khalil H, Badawy MH, Elkholy A, Eseily K, Anis S, Eldahshan S, Kamel N, Romeih M. Upregulation of Twist2 in Non-Muscle Invasive Urothelial Carcinoma of the Bladder Correlate with Response to Treatment and Progression. Open Access Maced J Med Sci 2018;6:1017-22. [PMID: 29983794 DOI: 10.3889/oamjms.2018.165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
225 Lencinas A, Broka DM, Konieczka JH, Klewer SE, Antin PB, Camenisch TD, Runyan RB. Arsenic exposure perturbs epithelial-mesenchymal cell transition and gene expression in a collagen gel assay. Toxicol Sci 2010;116:273-85. [PMID: 20308225 DOI: 10.1093/toxsci/kfq086] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
226 Geers B, De Wever O, Demeester J, Bracke M, De Smedt SC, Lentacker I. Targeted Liposome-Loaded Microbubbles for Cell-Specific Ultrasound-Triggered Drug Delivery. Small 2013;9:4027-35. [DOI: 10.1002/smll.201300161] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
227 Teo Z, Sng MK, Chan JSK, Lim MMK, Li Y, Li L, Phua T, Lee JYH, Tan ZW, Zhu P, Tan NS. Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial-mesenchymal transition by inducing 14-3-3γ expression. Oncogene 2017;36:6408-19. [PMID: 28745316 DOI: 10.1038/onc.2017.244] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
228 Stewart CJ, McCluggage WG. Epithelial-mesenchymal transition in carcinomas of the female genital tract. Histopathology 2013;62:31-43. [PMID: 23240668 DOI: 10.1111/his.12057] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
229 Sancisi V, Gandolfi G, Ragazzi M, Nicoli D, Tamagnini I, Piana S, Ciarrocchi A. Cadherin 6 is a new RUNX2 target in TGF-β signalling pathway. PLoS One 2013;8:e75489. [PMID: 24069422 DOI: 10.1371/journal.pone.0075489] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
230 Yamada E, Ishii G, Aramaki N, Aokage K, Hishida T, Yoshida J, Kojima M, Nagai K, Ochiai A. Tumor-size-based morphological features of metastatic lymph node tumors from primary lung adenocarcinoma. Pathol Int 2014;64:591-600. [PMID: 25354789 DOI: 10.1111/pin.12213] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
231 Liu W, Huang X, Liang X, Zhou Y, Li H, Yu Q, Li Q. Identification of Key Modules and Hub Genes of Keloids with Weighted Gene Coexpression Network Analysis. Plast Reconstr Surg 2017;139:376-90. [PMID: 28121871 DOI: 10.1097/PRS.0000000000003014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
232 Sato M, Shames DS, Hasegawa Y. Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis. Respirology 2012;17:1048-59. [PMID: 22452538 DOI: 10.1111/j.1440-1843.2012.02173.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 6.7] [Reference Citation Analysis]
233 Ungefroren H, Sebens S, Seidl D, Lehnert H, Hass R. Interaction of tumor cells with the microenvironment. Cell Commun Signal. 2011;9:18. [PMID: 21914164 DOI: 10.1186/1478-811x-9-18] [Cited by in Crossref: 173] [Cited by in F6Publishing: 111] [Article Influence: 15.7] [Reference Citation Analysis]
234 Goodson WH, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis. 2015;36 Suppl 1:S254-S296. [PMID: 26106142 DOI: 10.1093/carcin/bgv039] [Cited by in Crossref: 149] [Cited by in F6Publishing: 121] [Article Influence: 21.3] [Reference Citation Analysis]
235 Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, Polette M, Gilles C. Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia. 2010;15:261-273. [PMID: 20449641 DOI: 10.1007/s10911-010-9174-0] [Cited by in Crossref: 151] [Cited by in F6Publishing: 142] [Article Influence: 12.6] [Reference Citation Analysis]
236 Wang Z, Li Y, Kong D, Sarkar FH. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets. 2010;11:745-751. [PMID: 20041844 DOI: 10.2174/138945010791170860] [Cited by in Crossref: 180] [Cited by in F6Publishing: 179] [Article Influence: 15.0] [Reference Citation Analysis]
237 Porcheri C, Mitsiadis TA. Notch in Head and Neck Cancer. Adv Exp Med Biol 2021;1287:81-103. [PMID: 33034028 DOI: 10.1007/978-3-030-55031-8_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
238 Bronsert P, Enderle-Ammour K, Bader M, Timme S, Kuehs M, Csanadi A, Kayser G, Kohler I, Bausch D, Hoeppner J. Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface. J Pathol. 2014;234:410-422. [PMID: 25081610 DOI: 10.1002/path.4416] [Cited by in Crossref: 162] [Cited by in F6Publishing: 158] [Article Influence: 20.3] [Reference Citation Analysis]
239 Bansal N, Mims J, Kuremsky JG, Olex AL, Zhao W, Yin L, Wani R, Qian J, Center B, Marrs GS, Porosnicu M, Fetrow JS, Tsang AW, Furdui CM. Broad phenotypic changes associated with gain of radiation resistance in head and neck squamous cell cancer. Antioxid Redox Signal 2014;21:221-36. [PMID: 24597745 DOI: 10.1089/ars.2013.5690] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
240 Tian XJ, Zhang H, Xing J. Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition. Biophys J 2013;105:1079-89. [PMID: 23972859 DOI: 10.1016/j.bpj.2013.07.011] [Cited by in Crossref: 162] [Cited by in F6Publishing: 132] [Article Influence: 20.3] [Reference Citation Analysis]
241 Schmid SA, Dietrich A, Schulte S, Gaumann A, Kunz-Schughart LA. Fibroblastic reaction and vascular maturation in human colon cancers. Int J Radiat Biol 2009;85:1013-25. [PMID: 19895278 DOI: 10.3109/09553000903258897] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
242 Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703-719. [PMID: 22664915 DOI: 10.4161/rna.20481395] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
243 Gavert N, Ben-Ze'ev A. Coordinating changes in cell adhesion and phenotype during EMT-like processes in cancer. F1000 Biol Rep 2010;2:86. [PMID: 21283595 DOI: 10.3410/B2-86] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
244 Olsen L, Campos B, Winther O, Sgroi DC, Karger BL, Brusic V. Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas. BMC Med Genomics 2014;7 Suppl 3:S2. [PMID: 25521819 DOI: 10.1186/1755-8794-7-S3-S2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
245 Fan H, Atiya HI, Wang Y, Pisanic TR, Wang TH, Shih IM, Foy KK, Frisbie L, Buckanovich RJ, Chomiak AA, Tiedemann RL, Rothbart SB, Chandler C, Shen H, Coffman LG. Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis. Cell Rep 2020;33:108473. [PMID: 33296650 DOI: 10.1016/j.celrep.2020.108473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
246 Kestens C, Siersema PD, Offerhaus GJ, van Baal JW. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2. PLoS One 2016;11:e0155754. [PMID: 27191723 DOI: 10.1371/journal.pone.0155754] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
247 Yang X, Lee Y, Huang Y, Chen JL, Xing RH, Lussier YA. Stromal microenvironment processes unveiled by biological component analysis of gene expression in xenograft tumor models. BMC Bioinformatics 2010;11 Suppl 9:S11. [PMID: 21044358 DOI: 10.1186/1471-2105-11-S9-S11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
248 Ramos C, Becerril C, Montaño M, García-De-Alba C, Ramírez R, Checa M, Pardo A, Selman M. FGF-1 reverts epithelial-mesenchymal transition induced by TGF-{beta}1 through MAPK/ERK kinase pathway. Am J Physiol Lung Cell Mol Physiol 2010;299:L222-31. [PMID: 20495078 DOI: 10.1152/ajplung.00070.2010] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 7.4] [Reference Citation Analysis]
249 Peyre L, Zucchini-pascal N, de Sousa G, Rahmani R. Effects of endosulfan on hepatoma cell adhesion: Epithelial–mesenchymal transition and anoikis resistance. Toxicology 2012;300:19-30. [DOI: 10.1016/j.tox.2012.05.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
250 Shi M, Zheng D, Sun L, Wang L, Lin L, Wu Y, Zhou M, Liao W, Liao Y, Zuo Q. XB130 promotes proliferation and invasion of gastric cancer cells. J Transl Med. 2014;12:1. [PMID: 24387290 DOI: 10.1186/1479-5876-12-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
251 Soda K. The mechanisms by which polyamines accelerate tumor spread. J Exp Clin Cancer Res 2011;30:95. [PMID: 21988863 DOI: 10.1186/1756-9966-30-95] [Cited by in Crossref: 123] [Cited by in F6Publishing: 111] [Article Influence: 11.2] [Reference Citation Analysis]
252 Yi Y, Woo YM, Hwang KH, Kim HS, Lee SH. Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt-Axin2-Snail Cascade. Cancers (Basel) 2021;13:4630. [PMID: 34572856 DOI: 10.3390/cancers13184630] [Reference Citation Analysis]
253 Venables JP, Brosseau JP, Gadea G, Klinck R, Prinos P, Beaulieu JF, Lapointe E, Durand M, Thibault P, Tremblay K, Rousset F, Tazi J, Abou Elela S, Chabot B. RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues. Mol Cell Biol 2013;33:396-405. [PMID: 23149937 DOI: 10.1128/MCB.01174-12] [Cited by in Crossref: 88] [Cited by in F6Publishing: 66] [Article Influence: 8.8] [Reference Citation Analysis]
254 Lee HJ, Ormandy CJ. Elf5, hormones and cell fate. Trends Endocrinol Metab 2012;23:292-8. [PMID: 22464677 DOI: 10.1016/j.tem.2012.02.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
255 Voon DC, Wang H, Koo JK, Nguyen TA, Hor YT, Chu YS, Ito K, Fukamachi H, Chan SL, Thiery JP. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity. Stem Cells. 2012;30:2088-2099. [PMID: 22899304 DOI: 10.1002/stem.1183] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
256 Zhitnyak IY, Rubtsova SN, Litovka NI, Gloushankova NA. Early Events in Actin Cytoskeleton Dynamics and E-Cadherin-Mediated Cell-Cell Adhesion during Epithelial-Mesenchymal Transition. Cells 2020;9:E578. [PMID: 32121325 DOI: 10.3390/cells9030578] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
257 Yang H, Zhang Y, Zhou Z, Jiang X, Shen A. Transcription factor Snai1-1 induces osteosarcoma invasion and metastasis by inhibiting E-cadherin expression. Oncol Lett 2014;8:193-7. [PMID: 24959244 DOI: 10.3892/ol.2014.2079] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
258 Gjerdrum C, Tiron C, Høiby T, Stefansson I, Haugen H, Sandal T, Collett K, Li S, McCormack E, Gjertsen BT. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci USA. 2010;107:1124-1129. [PMID: 20080645 DOI: 10.1073/pnas.0909333107] [Cited by in Crossref: 368] [Cited by in F6Publishing: 343] [Article Influence: 28.3] [Reference Citation Analysis]
259 Trindade A, Duarte A. Notch Signaling Function in the Angiocrine Regulation of Tumor Development. Cells 2020;9:E2467. [PMID: 33198378 DOI: 10.3390/cells9112467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
260 Chen G, Liu H, Zhang Y, Liang J, Zhu Y, Zhang M, Yu D, Wang C, Hou J. Silencing PFKP inhibits starvation-induced autophagy, glycolysis, and epithelial mesenchymal transition in oral squamous cell carcinoma. Experimental Cell Research 2018;370:46-57. [DOI: 10.1016/j.yexcr.2018.06.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
261 Wollenberg B. Implication of stem cells in the biology and therapy of head and neck cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg 2011;10:Doc01. [PMID: 22558051 DOI: 10.3205/cto000074] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
262 Etemad-Moghadam S, Alaeddini M. Pattern of invasion in squamous cell carcinomas of the lower lip and oral cavity. J Oral Biol Craniofac Res 2017;7:167-70. [PMID: 29123994 DOI: 10.1016/j.jobcr.2017.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
263 Guadamillas MC, Cerezo A, Del Pozo MA. Overcoming anoikis--pathways to anchorage-independent growth in cancer. J Cell Sci 2011;124:3189-97. [PMID: 21940791 DOI: 10.1242/jcs.072165] [Cited by in Crossref: 240] [Cited by in F6Publishing: 231] [Article Influence: 24.0] [Reference Citation Analysis]
264 Zhang J, Tian X, Zhang H, Teng Y, Li R, Bai F, Elankumaran S, Xing J. TGF- -induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops. Science Signaling 2014;7:ra91-ra91. [DOI: 10.1126/scisignal.2005304] [Cited by in Crossref: 249] [Cited by in F6Publishing: 216] [Article Influence: 31.1] [Reference Citation Analysis]
265 Lencinas A, Chhun DC, Dan KP, Ross KD, Hoover EA, Antin PB, Runyan RB. Olfactomedin-1 activity identifies a cell invasion checkpoint during epithelial-mesenchymal transition in the chick embryonic heart. Dis Model Mech 2013;6:632-42. [PMID: 23264563 DOI: 10.1242/dmm.010595] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
266 Bielecka ZF, Czarnecka AM, Solarek W, Kornakiewicz A, Szczylik C. Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC). Curr Signal Transduct Ther 2014;8:218-28. [PMID: 25152704 DOI: 10.2174/1574362409666140206223014] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
267 de Andrade NP, Rodrigues MF, Rodini CO, Nunes FD. Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44high cells. Pathol Res Pract 2017;213:235-44. [PMID: 28214216 DOI: 10.1016/j.prp.2016.12.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
268 Moniri MR, Dai LJ, Warnock GL. The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells. Cancer Gene Ther. 2014;21:12-23. [PMID: 24384772 DOI: 10.1038/cgt.2013.83] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
269 Kaneyama T, Kobayashi S, Aoyagi D, Ehara T. Tranilast modulates fibrosis, epithelial-mesenchymal transition and peritubular capillary injury in unilateral ureteral obstruction rats. Pathology 2010;42:564-73. [PMID: 20854076 DOI: 10.3109/00313025.2010.508784] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
270 Bhat FA, Sharmila G, Balakrishnan S, Arunkumar R, Elumalai P, Suganya S, Raja Singh P, Srinivasan N, Arunakaran J. Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. J Nutr Biochem 2014;25:1132-9. [PMID: 25150162 DOI: 10.1016/j.jnutbio.2014.06.008] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 8.4] [Reference Citation Analysis]
271 Raviraj V, Zhang H, Chien HY, Cole L, Thompson EW, Soon L. Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas. Clin Exp Metastasis 2012;29:273-92. [PMID: 22271313 DOI: 10.1007/s10585-011-9450-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
272 Busaranon K, Plaimee P, Sritularak B, Chanvorachote P. Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells. J Nat Med 2016;70:18-27. [PMID: 26384689 DOI: 10.1007/s11418-015-0931-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
273 Guo S, Xu J, Xue R, Liu Y, Yu H. Overexpression of AIB1 correlates inversely with E-cadherin expression in pancreatic adenocarcinoma and may promote lymph node metastasis. Int J Clin Oncol 2014;19:319-24. [PMID: 23542947 DOI: 10.1007/s10147-013-0549-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
274 Hirakawa S, Tanemura A, Mori H, Katayama I, Hashimoto K. Multiple lymphadenopathy as an initial sign of extramammary Paget disease. Br J Dermatol 2011;164:200-3. [PMID: 20849466 DOI: 10.1111/j.1365-2133.2010.10052.x] [Reference Citation Analysis]
275 Li Q, Zhang C, Chen R, Xiong H, Qiu F, Liu S, Zhang M, Wang F, Wang Y, Zhou X, Xiao G, Wang X, Jiang Q. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma. Cancer Lett 2016;383:28-40. [PMID: 27693631 DOI: 10.1016/j.canlet.2016.09.019] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 11.8] [Reference Citation Analysis]
276 von Hertzen LC, Joensuu H, Haahtela T. Microbial deprivation, inflammation and cancer. Cancer Metastasis Rev 2011;30:211-23. [DOI: 10.1007/s10555-011-9284-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
277 Zhang ZF, Qin RY, Zhu F, Wang M, Li X, Shi CJ. TGF-β1-induced epithelial-mesenchymal transition increases the abundance of side population cells in human gallbladder cancer cell line GBC-SD. Shijie Huaren Xiaohua Zazhi 2011; 19(16): 1680-1685 [DOI: 10.11569/wcjd.v19.i16.1680] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
278 Reinertsen T, Halgunset J, Viset T, Flatberg A, Haugsmoen LL, Skogseth H. Gene expressional changes in prostate fibroblasts from cancerous tissue. APMIS 2012;120:558-71. [PMID: 22716211 DOI: 10.1111/j.1600-0463.2011.02865.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
279 Puchinskaya MV. Epithelial-mesenchymal transition in health and disease. Arkh patol 2015;77:75. [DOI: 10.17116/patol201577175-] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
280 Nolte DD, An R, Turek J, Jeong K. Tissue dynamics spectroscopy for phenotypic profiling of drug effects in three-dimensional culture. Biomed Opt Express 2012;3:2825-41. [PMID: 23162721 DOI: 10.1364/BOE.3.002825] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
281 Wang C, Li L, Fu D, Qin T, Ran Y, Xu F, Du X, Gao H, Sun S, Yang T, Zhang X, Huo J, Zhao W, Zhang Z, Shi X. Discovery of chalcone-modified estradiol analogs as antitumour agents that Inhibit tumour angiogenesis and epithelial to mesenchymal transition. Eur J Med Chem 2019;176:135-48. [PMID: 31102934 DOI: 10.1016/j.ejmech.2019.04.071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
282 Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol. 2014;16:488-494. [PMID: 24875735 DOI: 10.1038/ncb2976] [Cited by in Crossref: 532] [Cited by in F6Publishing: 527] [Article Influence: 66.5] [Reference Citation Analysis]
283 Scarano WR, Pinho CF, Pissinatti L, Gonçalves BF, Mendes LO, Campos SG. Cell junctions in the prostate: an overview about the effects of Endocrine Disrupting Chemicals (EDCS) in different experimental models. Reproductive Toxicology 2018;81:147-54. [DOI: 10.1016/j.reprotox.2018.08.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
284 Ricciardi M, Zanotto M, Malpeli G, Bassi G, Perbellini O, Chilosi M, Bifari F, Krampera M. Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. Br J Cancer. 2015;112:1067-1075. [PMID: 25668006 DOI: 10.1038/bjc.2015.29] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 11.3] [Reference Citation Analysis]
285 Jin R, Chen X, Han D, Luo X, Li H. Clusterin modulates transdifferentiation of non-small-cell lung cancer. BMC Cancer 2017;17:661. [PMID: 28954633 DOI: 10.1186/s12885-017-3649-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
286 Freire-de-Lima L. Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition. Front Oncol 2014;4:59. [PMID: 24724053 DOI: 10.3389/fonc.2014.00059] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
287 Chen H, Takahara M, Xie L, Takeuchi S, Tu Y, Nakahara T, Uchi H, Moroi Y, Furue M. Levels of the EMT-related protein Snail/Slug are not correlated with p53/p63 in cutaneous squamous cell carcinoma. J Cutan Pathol 2013;40:651-6. [PMID: 23521708 DOI: 10.1111/cup.12142] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
288 Zhang X, Han J, Feng L, Zhi L, Jiang D, Yu B, Zhang Z, Gao B, Zhang C, Li M, Zhao L, Wang G. DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3. Carcinogenesis 2021;42:105-17. [PMID: 32531052 DOI: 10.1093/carcin/bgaa056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
289 Wierstra I. FOXM1 (Forkhead box M1) in Tumorigenesis. Elsevier; 2013. pp. 191-419. [DOI: 10.1016/b978-0-12-407190-2.00016-2] [Cited by in Crossref: 103] [Cited by in F6Publishing: 71] [Article Influence: 11.4] [Reference Citation Analysis]
290 Lin X, Shang X, Manorek G, Howell SB. Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4. PLoS One 2013;8:e67496. [PMID: 23805314 DOI: 10.1371/journal.pone.0067496] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
291 Sume SS, Berker E, Ilarslan Y, Ozer Yucel O, Tan C, Goyushov S, Gultekin SE, Tezcan I. Elevated Interleukin-17A expression in amlodipine-induced gingival overgrowth. J Periodontal Res 2020;55:613-21. [PMID: 32173874 DOI: 10.1111/jre.12747] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
292 Liu T, Zhao L, Zhang Y, Chen W, Liu D, Hou H, Ding L, Li X. Ginsenoside 20(S)-Rg3 targets HIF-1α to block hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells. PLoS One 2014;9:e103887. [PMID: 25197976 DOI: 10.1371/journal.pone.0103887] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
293 Wang C, Zhang R, Wang X, Zheng Y, Jia H, Li H, Wang J, Wang N, Xiang F, Li Y. Silencing of KIF3B Suppresses Breast Cancer Progression by Regulating EMT and Wnt/β-Catenin Signaling. Front Oncol 2020;10:597464. [PMID: 33542902 DOI: 10.3389/fonc.2020.597464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Li HY, Li Y, Liu D, Sun HZ, Liu JG. LPS regulates epithelial-mesenchymal transition in cholangiocarcinoma cell line ICBD via the p38/MAPK signaling pathway. Shijie Huaren Xiaohua Zazhi 2013; 21(21): 2070-2075 [DOI: 10.11569/wcjd.v21.i21.2070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
295 Kirkland SC. Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells. Br J Cancer. 2009;101:320-326. [PMID: 19568234 DOI: 10.1038/sj.bjc.6605143] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 5.6] [Reference Citation Analysis]
296 Sirica AE, Campbell DJ, Dumur CI. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2011;27:276-84. [PMID: 21297470 DOI: 10.1097/MOG.0b013e32834405c3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
297 Jacob S, Nayak S, Fernandes G, Barai RS, Menon S, Chaudhari UK, Kholkute SD, Sachdeva G. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer. Endocr Relat Cancer 2014;21:473-86. [PMID: 24812058 DOI: 10.1530/ERC-13-0514] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
298 Ran J, Lin DL, Wu RF, Chen QH, Huang HP, Qiu NX, Quan S. ZEB1 promotes epithelial-mesenchymal transition in cervical cancer metastasis. Fertil Steril 2015;103:1606-14.e1-2. [PMID: 25963537 DOI: 10.1016/j.fertnstert.2015.03.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
299 Jinka R, Kapoor R, Pavuluri S, Raj AT, Kumar MJ, Rao L, Pande G. Differential gene expression and clonal selection during cellular transformation induced by adhesion deprivation. BMC Cell Biol 2010;11:93. [PMID: 21122158 DOI: 10.1186/1471-2121-11-93] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
300 De Souza C, Madden JA, Minn D, Kumar VE, Montoya DJ, Nambiar R, Zhu Z, Xiao WW, Tahmassebi N, Kathi H, Nelson N, Karnezis AN, Chien J. The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression. Int J Mol Sci 2020;21:E8025. [PMID: 33126568 DOI: 10.3390/ijms21218025] [Reference Citation Analysis]
301 Cursons J, Leuchowius KJ, Waltham M, Tomaskovic-Crook E, Foroutan M, Bracken CP, Redfern A, Crampin EJ, Street I, Davis MJ, Thompson EW. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines. Cell Commun Signal 2015;13:26. [PMID: 25975820 DOI: 10.1186/s12964-015-0106-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
302 Katayama H, Boldt C, Ladd JJ, Johnson MM, Chao T, Capello M, Suo J, Mao J, Manson JE, Prentice R, Esteva F, Wang H, Disis ML, Hanash S. An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis. Cancer Res 2015;75:3246-54. [PMID: 26088128 DOI: 10.1158/0008-5472.CAN-15-0248] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
303 Lin Z, Fan Z, Zhang X, Wan J, Liu T. Cellular plasticity and drug resistance in sarcoma. Life Sci 2020;263:118589. [PMID: 33069737 DOI: 10.1016/j.lfs.2020.118589] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
304 Nonpanya N, Sanookpan K, Sriratanasak N, Vinayanuwattikun C, Wichadakul D, Sritularak B, Chanvorachote P. Artocarpin Targets Focal Adhesion Kinase-Dependent Epithelial to Mesenchymal Transition and Suppresses Migratory-Associated Integrins in Lung Cancer Cells. Pharmaceutics 2021;13:554. [PMID: 33920031 DOI: 10.3390/pharmaceutics13040554] [Reference Citation Analysis]
305 Ishiguro Y, Sakihama H, Yoshida T, Ichikawa N, Homma S, Fukai M, Kawamura H, Takahashi N, Taketomi A. Prognostic Significance of Circulating Tumor Cells with Mesenchymal Phenotypes in Patients with Gastric Cancer: A Prospective Study. Ann Surg Oncol 2021;28:1178-86. [PMID: 32770296 DOI: 10.1245/s10434-020-08827-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
306 Savagner P. [Epithelial-mesenchymal transition: the concept]. Ann Pathol 2009;29 Spec No 1:S59-60. [PMID: 19887253 DOI: 10.1016/j.annpat.2009.07.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
307 Odaert B, Prouzet-mauleon V, Dupuy J, Crouzet M, Bonneu M, Santarelli X, Vieillemard A, Thoraval D, Doignon F, Hugues M. Evidence for specific interaction between the RhoGAP domain from the yeast Rgd1 protein and phosphoinositides. Biochemical and Biophysical Research Communications 2011;405:74-8. [DOI: 10.1016/j.bbrc.2010.12.130] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
308 Sethi S, Sarkar FH, Ahmed Q, Bandyopadhyay S, Nahleh ZA, Semaan A, Sakr W, Munkarah A, Ali-Fehmi R. Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma. Transl Oncol 2011;4:222-6. [PMID: 21804917 DOI: 10.1593/tlo.10244] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
309 Kim SM, Han J, Park SM. The Role of Epithelial-mesenchymal Transition in the Gastroenterology. Korean J Gastroenterol 2010;56:69. [DOI: 10.4166/kjg.2010.56.2.69] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
310 Harris K, Gelberg HB, Kiupel M, Helfand SC. Immunohistochemical Features of Epithelial-Mesenchymal Transition in Feline Oral Squamous Cell Carcinoma. Vet Pathol 2019;56:826-39. [PMID: 31331247 DOI: 10.1177/0300985819859873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
311 Gloushankova NA, Zhitnyak IY, Rubtsova SN. Role of Epithelial-Mesenchymal Transition in Tumor Progression. Biochemistry Moscow 2018;83:1469-76. [DOI: 10.1134/s0006297918120052] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
312 Petrakis D, Vassilopoulou L, Mamoulakis C, Psycharakis C, Anifantaki A, Sifakis S, Docea AO, Tsiaoussis J, Makrigiannakis A, Tsatsakis AM. Endocrine Disruptors Leading to Obesity and Related Diseases. Int J Environ Res Public Health 2017;14:E1282. [PMID: 29064461 DOI: 10.3390/ijerph14101282] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 17.0] [Reference Citation Analysis]
313 Bebee TW, Cieply BW, Carstens RP. Genome-wide activities of RNA binding proteins that regulate cellular changes in the epithelial to mesenchymal transition (EMT). Adv Exp Med Biol 2014;825:267-302. [PMID: 25201109 DOI: 10.1007/978-1-4939-1221-6_8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
314 Morel AP, Hinkal GW, Thomas C, Fauvet F, Courtois-Cox S, Wierinckx A, Devouassoux-Shisheboran M, Treilleux I, Tissier A, Gras B, Pourchet J, Puisieux I, Browne GJ, Spicer DB, Lachuer J, Ansieau S, Puisieux A. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet 2012;8:e1002723. [PMID: 22654675 DOI: 10.1371/journal.pgen.1002723] [Cited by in Crossref: 115] [Cited by in F6Publishing: 118] [Article Influence: 11.5] [Reference Citation Analysis]
315 Mooney SM, Jolly MK, Levine H, Kulkarni P. Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins. Asian J Androl 2016;18:704-10. [PMID: 27427552 DOI: 10.4103/1008-682X.183570] [Cited by in Crossref: 46] [Cited by in F6Publishing: 23] [Article Influence: 9.2] [Reference Citation Analysis]
316 Azoitei N, Cobbaut M, Becher A, Van Lint J, Seufferlein T. Protein kinase D2: a versatile player in cancer biology. Oncogene 2018;37:1263-78. [PMID: 29259300 DOI: 10.1038/s41388-017-0052-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
317 Williams ED, Gao D, Redfern A, Thompson EW. Controversies around epithelial-mesenchymal plasticity in cancer metastasis. Nat Rev Cancer 2019;19:716-32. [PMID: 31666716 DOI: 10.1038/s41568-019-0213-x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 112] [Article Influence: 39.3] [Reference Citation Analysis]
318 Berke TP, Slight SH, Hyder SM. Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer. Onco Targets Ther 2022;15:23-30. [PMID: 35035222 DOI: 10.2147/OTT.S342292] [Reference Citation Analysis]
319 Blackwell RH, Foreman KE, Gupta GN. The Role of Cancer-Derived Exosomes in Tumorigenicity & Epithelial-to-Mesenchymal Transition. Cancers (Basel) 2017;9:E105. [PMID: 28796150 DOI: 10.3390/cancers9080105] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
320 Yashiro M, Matsuoka T, Ohira M. The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models. Hum Cell 2018;31:271-81. [PMID: 29876827 DOI: 10.1007/s13577-018-0211-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
321 Theveneau E, Mayor R. Collective cell migration of epithelial and mesenchymal cells. Cell Mol Life Sci 2013;70:3481-92. [PMID: 23314710 DOI: 10.1007/s00018-012-1251-7] [Cited by in Crossref: 94] [Cited by in F6Publishing: 75] [Article Influence: 10.4] [Reference Citation Analysis]
322 Mitra A, Menezes ME, Shevde LA, Samant RS. DNAJB6 induces degradation of beta-catenin and causes partial reversal of mesenchymal phenotype. J Biol Chem. 2010;285:24686-24694. [PMID: 20522561 DOI: 10.1074/jbc.m109.094847] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
323 Thomas VT, Hinson S, Konduri K. Epithelial-mesenchymal transition in pulmonary carcinosarcoma: case report and literature review. Ther Adv Med Oncol 2012;4:31-7. [PMID: 22229046 DOI: 10.1177/1758834011421949] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
324 Hong IS, Lee HY, Kang KS. Mesenchymal stem cells and cancer: friends or enemies? Mutat Res. 2014;768:98-106. [PMID: 24512984 DOI: 10.1016/j.mrfmmm.2014.01.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
325 Bonnomet A, Syne L, Brysse A, Feyereisen E, Thompson EW, Noël A, Foidart JM, Birembaut P, Polette M, Gilles C. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene. 2012;31:3741-3753. [PMID: 22120722 DOI: 10.1038/onc.2011.540] [Cited by in Crossref: 131] [Cited by in F6Publishing: 124] [Article Influence: 11.9] [Reference Citation Analysis]
326 Ollivier L, Labbé M, Fradin D, Potiron V, Supiot S. Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer. Front Oncol 2021;11:744679. [PMID: 34595122 DOI: 10.3389/fonc.2021.744679] [Reference Citation Analysis]
327 Li Y, Yan X, Ren L, Li Y. miR-644a Inhibits Cellular Proliferation and Invasion via Suppression of CtBP1 in Gastric Cancer Cells. Oncol Res 2018;26:1-8. [PMID: 27983935 DOI: 10.3727/096504016X14772410356982] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
328 Del Valle Guaytima E, Brandán YR, Favale NO, Sterin-Speziale NB, Márquez MG. Novel cellular mechanism that mediates the collecting duct formation during postnatal renal development. J Cell Physiol 2019;234:13387-402. [PMID: 30624780 DOI: 10.1002/jcp.28016] [Reference Citation Analysis]
329 Bongiovanni L, D'Andrea A, Romanucci M, Malatesta D, Candolini M, Salda LD, Mechelli L, Sforna M, Brachelente C. Epithelial-to-mesenchymal transition: immunohistochemical investigation of related molecules in canine cutaneous epithelial tumours. Vet Dermatol 2013;24:195-203.e42-3. [PMID: 23331698 DOI: 10.1111/j.1365-3164.2012.01116.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
330 Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol. 2010;21 Suppl 7:vii89-vii92. [PMID: 20943648 DOI: 10.1093/annonc/mdq292] [Cited by in Crossref: 230] [Cited by in F6Publishing: 239] [Article Influence: 20.9] [Reference Citation Analysis]
331 Katz E, Dubois-Marshall S, Sims AH, Gautier P, Caldwell H, Meehan RR, Harrison DJ. An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer. PLoS One 2011;6:e17083. [PMID: 21347235 DOI: 10.1371/journal.pone.0017083] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
332 Dong T, Yang D, Li R, Zhang L, Zhao H, Shen Y, Zhang X, Kong B, Wang L. PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts. Exp Mol Pathol 2016;100:17-25. [PMID: 26607602 DOI: 10.1016/j.yexmp.2015.11.021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
333 Dai LJ, Moniri MR, Zeng ZR, Zhou JX, Rayat J, Warnock GL. Potential implications of mesenchymal stem cells in cancer therapy. Cancer Lett. 2011;305:8-20. [PMID: 21396770 DOI: 10.1016/j.canlet.2011.02.012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 6.2] [Reference Citation Analysis]